Cargando…
Retracted: Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways
Autor principal: | International, BioMed Research |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356204/ https://www.ncbi.nlm.nih.gov/pubmed/37475820 http://dx.doi.org/10.1155/2023/9803081 |
Ejemplares similares
-
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways
por: Wang, Kun, et al.
Publicado: (2021) -
Retracted: The Expression of the Long Noncoding RNA AFAP1-AS1 in Laryngeal Carcinoma Affects the Proliferation, Invasion, Migration, and Apoptosis of TU212 Cell Line
por: International, BioMed Research
Publicado: (2023) -
Retracted: Predicting the Growth of F. proliferatum and F. culmorum and the Growth of Mycotoxin Using Machine Learning Approach
por: International, BioMed Research
Publicado: (2023) -
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain
por: Marchalant, Y, et al.
Publicado: (2009) -
Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
por: Gercek, Oyku Zeynep, et al.
Publicado: (2020)